BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 29080242)

  • 1. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
    Tran BV; Ujita K; Taketomi-Takahashi A; Hirasawa H; Suto T; Tsushima Y
    PLoS One; 2021; 16(8):e0255768. PubMed ID: 34383812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive quantification of hepatic steatosis in living, related liver donors using dual-echo Dixon imaging and single-voxel proton spectroscopy.
    Krishan S; Jain D; Bathina Y; Kale A; Saraf N; Saigal S; Choudhary N; Baijal SS; Soin A
    Clin Radiol; 2016 Jan; 71(1):58-63. PubMed ID: 26555703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutoff Values for Diagnosing Hepatic Steatosis Using Contemporary MRI-Proton Density Fat Fraction Measuring Methods.
    Park S; Kwon JH; Kim SY; Kang JH; Chung JI; Jang JK; Jang HY; Shim JH; Lee SS; Kim KW; Song GW
    Korean J Radiol; 2022 Dec; 23(12):1260-1268. PubMed ID: 36447414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy.
    Hwang I; Lee JM; Lee KB; Yoon JH; Kiefer B; Han JK; Choi BI
    Radiology; 2014 Jun; 271(3):730-8. PubMed ID: 24533869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hepatic steatosis and iron content at 3 Tesla: comparison of two-point Dixon, quantitative multi-echo Dixon, and MR spectroscopy.
    Zhan C; Olsen S; Zhang HC; Kannengiesser S; Chandarana H; Shanbhogue KP
    Abdom Radiol (NY); 2019 Sep; 44(9):3040-3048. PubMed ID: 31286208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing hepatic steatosis by magnetic resonance in potential living liver donors.
    Kuru Öz D; Ellik Z; Gürsoy Çoruh A; Adıgüzel M; Gümüşsoy M; Kiremitci S; Kırımker OE; Gökcan H; Elhan AH; Balcı D; Savaş B; Erden A; İdilman R
    Diagn Interv Radiol; 2024 May; ():. PubMed ID: 38737404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.
    Bannas P; Kramer H; Hernando D; Agni R; Cunningham AM; Mandal R; Motosugi U; Sharma SD; Munoz del Rio A; Fernandez L; Reeder SB
    Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents.
    Di Martino M; Pacifico L; Bezzi M; Di Miscio R; Sacconi B; Chiesa C; Catalano C
    World J Gastroenterol; 2016 Oct; 22(39):8812-8819. PubMed ID: 27818597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.
    Vu KN; Gilbert G; Chalut M; Chagnon M; Chartrand G; Tang A
    J Magn Reson Imaging; 2016 May; 43(5):1090-9. PubMed ID: 26536609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.
    Park CC; Hooker C; Hooker JC; Bass E; Haufe W; Schlein A; Covarrubias Y; Heba E; Bydder M; Wolfson T; Gamst A; Loomba R; Schwimmer J; Hernando D; Reeder SB; Middleton M; Sirlin CB; Hamilton G
    J Magn Reson Imaging; 2019 Jan; 49(1):229-238. PubMed ID: 29707848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a motion-robust 2D sequential technique for quantification of hepatic proton density fat fraction during free breathing.
    Pooler BD; Hernando D; Ruby JA; Ishii H; Shimakawa A; Reeder SB
    J Magn Reson Imaging; 2018 Dec; 48(6):1578-1585. PubMed ID: 29665193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.
    Zand KA; Shah A; Heba E; Wolfson T; Hamilton G; Lam J; Chen J; Hooker JC; Gamst AC; Middleton MS; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2015 Nov; 42(5):1223-32. PubMed ID: 25847512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques.
    Wu CH; Ho MC; Jeng YM; Hsu CY; Liang PC; Hu RH; Lai HS; Shih TT
    J Gastroenterol Hepatol; 2014 Apr; 29(4):807-13. PubMed ID: 24224538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a 3% Proton Density Fat Fraction as a Cut-Off Value Increases Sensitivity of Detection of Hepatic Steatosis, Based on Results From Histopathology Analysis.
    Nasr P; Forsgren MF; Ignatova S; Dahlström N; Cedersund G; Leinhard OD; Norén B; Ekstedt M; Lundberg P; Kechagias S
    Gastroenterology; 2017 Jul; 153(1):53-55.e7. PubMed ID: 28286210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.
    Achmad E; Yokoo T; Hamilton G; Heba ER; Hooker JC; Changchien C; Schroeder M; Wolfson T; Gamst A; Schwimmer JB; Lavine JE; Sirlin CB; Middleton MS
    Abdom Imaging; 2015 Oct; 40(8):3084-90. PubMed ID: 26205992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of Multi-echo Dixon Sequence in Quantification of Hepatic Steatosis.
    Yurdaisik I; Nurili F
    Cureus; 2020 Feb; 12(2):e7103. PubMed ID: 32231898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.